Lawlor Augustine is a director of Gyre Therapeutics Inc.
Person profile
Roles
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
LEAP THERAPEUTICS, INC.
31 Jan 24
4
LEAP THERAPEUTICS, INC.
30 Jan 24
4
CATALYST BIOSCIENCES, INC.
1 Sep 23
4
LEAP THERAPEUTICS, INC.
25 Aug 23
4
Cardiovascular Systems Inc
27 Apr 23
4
LEAP THERAPEUTICS, INC.
4 Apr 23
4
LEAP THERAPEUTICS, INC.
2 Sep 22
4
Cardiovascular Systems Inc
9 Aug 22
4
LEAP THERAPEUTICS, INC.
2 Feb 22
4
Cardiovascular Systems Inc
17 Nov 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Jan 24 | LPTX Leap Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 2.68 | 85,000 | 227.80 k | 85,000 |
26 Jan 24 | LPTX Leap Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 5,000 | 0.00 | 5,086 |
26 Jan 24 | LPTX Leap Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 5,000 | 0.00 | 0 |
31 Aug 23 | GYRE Gyre Therapeutics | Series Y Preferred Stock | Sale back to company | Dispose D | Yes | No | 0 | 24.215 | 0.00 | 0 |
31 Aug 23 | GYRE Gyre Therapeutics | Series Y Preferred Stock | Sale back to company | Dispose D | No | No | 0 | 24.573 | 0.00 | 0 |
23 Aug 23 | LPTX Leap Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 2.21 | 70,000 | 154.70 k | 70,000 |
27 Apr 23 | CSII Cardiovascular Systems | Common Stock | Sale back to company | Dispose D | Yes | No | 20 | 25,318 | 506.36 k | 0 |
27 Apr 23 | CSII Cardiovascular Systems | Common Stock | Sale back to company | Dispose D | No | No | 20 | 5,022 | 100.44 k | 0 |
27 Apr 23 | CSII Cardiovascular Systems | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 103,719 | 0.00 | 0 |